Biohaven (BHVN) Other Non-Current Assets (2021 - 2026)

Biohaven's (BHVN) quarterly Other Non-Current Assets came in at $45.7 million in Q1 2026, up 18.39% year-on-year from $38.6 million in Q1 2025, and down 3.49% quarter-over-quarter from $47.4 million in Q4 2025.

Biohaven (BHVN) Other Non-Current Assets (2021 - 2026) Analysis & Trends

Biohaven has disclosed Other Non-Current Assets across 6 years of filings, most recently posting $45.7 million for Q1 2026.

  • Other Non-Current Assets for Q1 2026 came in at $45.7 million, up 18.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $45.7 million (up 18.39% YoY), and the FY2025 annual result was $47.4 million, up 19.83% from the prior year.
  • Other Non-Current Assets came in at $45.7 million for Q1 2026 at Biohaven, down from $47.4 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $48.2 million in Q3 2025 to a low of $17.9 million in Q3 2022.
  • The 5-year median for Other Non-Current Assets is $36.8 million (2023), against an average of $36.7 million.
  • Across the five-year window, Other Non-Current Assets surged 159.82% in 2022 and slipped 9.94% in 2023, its largest moves.
  • Biohaven's Other Non-Current Assets stood at $37.5 million in 2022, then retreated by 9.94% to $33.8 million in 2023, then rose by 16.99% to $39.5 million in 2024, then increased by 19.83% to $47.4 million in 2025, then declined by 3.49% to $45.7 million in 2026.
  • The last three Other Non-Current Assets figures came in at $45.7 million (Q1 2026), $47.4 million (Q4 2025), and $48.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 12.40 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 60,000.00
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 1.26 Bn
9 Abivax 91.71 Bn 91.71 Bn - -
10 Biohaven 1.62 Bn 1.27 Bn - 45.71 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 45.71 Mn
Dec 31, 2025 47.36 Mn
Sep 30, 2025 48.20 Mn
Jun 30, 2025 37.21 Mn
Mar 31, 2025 38.61 Mn
Dec 31, 2024 39.53 Mn
Sep 30, 2024 31.96 Mn
Jun 30, 2024 32.92 Mn
Mar 31, 2024 33.31 Mn
Dec 31, 2023 33.79 Mn
Sep 30, 2023 34.71 Mn
Jun 30, 2023 35.55 Mn
Mar 31, 2023 36.76 Mn
Dec 31, 2022 37.51 Mn
Sep 30, 2022 17.88 Mn
Dec 31, 2021 14.44 Mn